Sign in Subscribe
COVID-19

mRNA Vaccines Show Promise in Cancer Treatment

Strategic Insights

— 1 min read

Scientists at Massachusetts Institute of Technology have made a significant breakthrough in the field of cancer treatment, using the same mRNA technology that was successful in developing COVID-19 vaccines. By learning how to "awaken" T cells and reinvigorate the body's natural cancer-fighting abilities, researchers hope to develop new precision cancer vaccines that can target and kill cancer cells while leaving healthy cells untouched. This innovative approach has shown promising results in early studies, with tumors shrinking by more than 25 percent on average in mice with lung tumors.

Key Takeaways:

  • Researchers have developed a strategy to "awaken" T cells and reinvigorate the body's natural cancer-fighting abilities using mRNA technology.
  • The strategy involves vaccinating mice with weak neoantigens that provide a signal to immune cells, allowing suppressed T cells to grow and target tumors.
  • The approach has shown promising results in early studies, with tumors shrinking by more than 25 percent on average in mice with lung tumors.
  • The researchers hope to learn if this approach might work better when used in combination with immunotherapy drugs.
  • The success of mRNA vaccines for COVID-19 could potentially be used to speed up the development and testing of future cancer vaccines.
  • Researchers plan to continue refining the selection of protein targets on tumors to boost the immune response.

Statistics:

  • Tumors shrank by more than 25 percent on average in mice with lung tumors in early studies.
  • The researchers used mice with lung tumors to test their approach.
  • The approach involves vaccinating mice with weak neoantigens that provide a signal to immune cells.
  • The study was funded by the National Institutes of Health (NIH).
  • The researchers plan to continue refining the selection of protein targets on tumors to boost the immune response.

Sources:

[1] "T Cell Exhaustion Limits the Efficacy of Cancer Vaccines" - Cell (journal) [2] Massachusetts Institute of Technology (MIT) press release

Read more